Pacira Biosciences Inc.

Pacira BioSciences delivers US‑based non‑opioid pain solutions—EXPAREL, ZILRETTA, and iovera cryo‑analgesia—and develops PCRX‑201 gene therapy, positioning itself as a leader in post‑surgical and osteoarthritis markets.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical Practices

Employees: 788
HQ: Tampa

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
PCRX	Pacira Biosciences Inc. Cap: 1.1B \| P/E: 51.0	EQUITY	NMS	USD	US6951271005	Active	📈